In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype

[1]  C. Pui,et al.  Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region , 2002, The Lancet.

[2]  C. Pui,et al.  Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance , 2002, Leukemia.

[3]  C. Pui,et al.  Biological and therapeutic aspects of infant leukemia. , 2000, Blood.

[4]  E. Shacter,et al.  Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. , 2000, Blood.

[5]  P. Sonneveld,et al.  The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia. , 2000, International journal of clinical pharmacology and therapeutics.

[6]  H. Beverloo,et al.  Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set , 1999, Leukemia.

[7]  A. Borkhardt,et al.  Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. , 1999, Blood.

[8]  D. Arthur,et al.  Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) – a report of the Children’s Cancer Group , 1999, Leukemia.

[9]  N. Heerema,et al.  Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  G. Peters,et al.  Differential Methotrexate Resistance in Childhood T- Versus Common/PreB-Acute Lymphoblastic Leukemia Can Be Measured by an In Situ Thymidylate Synthase Inhibition Assay, But Not by the MTT Assay , 1999 .

[11]  M. D. Boer,et al.  Mechanisms of cellular anthracycline resistance in childhood acute leukemia , 1998, Leukemia.

[12]  D. Wang,et al.  Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis , 1998, Leukemia.

[13]  E. Thiel,et al.  Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. , 1998, Blood.

[14]  M. D. Boer,et al.  Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants , 1998, Leukemia.

[15]  J. V. van Dongen,et al.  Intensified therapy for infants with acute lymphoblastic leukemia , 1998 .

[16]  R. Pieters,et al.  Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. , 1998, Blood.

[17]  A. Borkhardt,et al.  Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. , 1997, Blood.

[18]  R. Gelber,et al.  Intensified therapy for infants with acute lymphoblastic leukemia , 1997, Cancer.

[19]  M. D. Boer,et al.  Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia , 1997, Leukemia.

[20]  T. Hongo,et al.  In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. , 1997, Blood.

[21]  M. Greaves.  Infant leukaemia biology, aetiology and treatment. , 1996, Leukemia.

[22]  F. Behm,et al.  Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. , 1996, The Journal of clinical investigation.

[23]  N. Heerema,et al.  Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4; 11)(q21; q23). , 1995, Blood.

[24]  C. Mecucci,et al.  Translocation (11;15)(q23;q14) in three patients with acute non-lymphoblastic leukemia (ANLL): clinical, cytogenetic and molecular studies. , 1995, Leukemia.

[25]  H. Clevers,et al.  The drug resistance-related protein LRP is the human major vault protein , 1995, Nature Medicine.

[26]  R. Pieters,et al.  Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. , 1994, British Journal of Cancer.

[27]  G. Basso,et al.  The role of immunophenotype in acute lymphoblastic leukemia of infant age. , 1994, Leukemia & lymphoma.

[28]  J. Shuster,et al.  Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1994, Blood.

[29]  R. Pieters,et al.  Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report. , 1994, Leukemia.

[30]  M. Slovak,et al.  Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. , 1993, Cancer research.

[31]  R. Pieters,et al.  In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. , 1991, British Journal of Cancer.

[32]  R. Pieters,et al.  Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia , 1991, The Lancet.

[33]  R. Pieters,et al.  Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. , 1988, Cancer letters.

[34]  P Berg,et al.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. , 1977, Journal of molecular biology.

[35]  M. Graham,et al.  A Preliminary Report , 1953 .

[36]  R. Pieters,et al.  In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. , 1997, Blood.

[37]  F. Behm,et al.  11q23 rearrangements in acute leukemia. , 1996, Leukemia.

[38]  A. Borkhardt,et al.  Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis. , 1995, Leukemia.

[39]  J. Wiegant,et al.  Detection of the Philadelphia chromosome in interphase nuclei. , 1990, Cytogenetics and cell genetics.

[40]  R. Pieters,et al.  In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. , 1990, Blood.